Valopicitabine

Valopicitabine (NM-283) is an antiviral drug which was developed as a treatment for hepatitis C, though only progressed as far as Phase III clinical trials. It acts as an RNA-dependent RNA polymerase inhibitor. It is a prodrug which is converted inside the body to the active form, 2'-C-methylcytidine triphosphate.^{[1][2][3][4][5]}

ATC code

• None

Legal status

• US: Investigational drug

CAS Number

• 640281-90-9

PubChem CID

• 6918726

Quick facts Clinical data, ATC code ...

Valopicitabine

Clinical data
ATC code	None
Legal status
Legal status	US: Investigational drug
Identifiers
IUPAC name [(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)-4-methyloxolan-3-yl] (2S)-2-amino-3-methylbutanoate
CAS Number	640281-90-9
PubChem CID	6918726
DrugBank	DB13920
ChemSpider	5293918
UNII	I2T0B5G94M
KEGG	D09028
ChEMBL	ChEMBL1743757
CompTox Dashboard (EPA)	DTXSID70214011
Chemical and physical data
Formula	C15H24N4O6
Molar mass	356.379 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C)[C@@H](C(=O)O[C@@H]1[C@H](O[C@H]([C@]1(C)O)N2C=CC(=NC2=O)N)CO)N
InChI InChI=1S/C15H24N4O6/c1-7(2)10(17)12(21)25-11-8(6-20)24-13(15(11,3)23)19-5-4-9(16)18-14(19)22/h4-5,7-8,10-11,13,20,23H,6,17H2,1-3H3,(H2,16,18,22)/t8-,10+,11-,13-,15-/m1/s1 Key:TVRCRTJYMVTEFS-ICGCPXGVSA-N

Close